Zdrowie i gospodarka · 17/11/2017
FDA Announces Draft Guidance for Expedited Review of Regenerative Medicine Therapies for Serious Conditions
The FDA is releasing a draft document outlining its expedited review process for regenerative medicine therapies aimed at treating serious or life-threatening diseases, with the goal of accelerating the development and approval of these treatments.